Adjunct Professor of Urology
Medical Director of Clinical Quality and Training
Professor of Health Management and Policy
[email protected]
Available to mentor
John M Hollingsworth
Professor
-
Hsi RS, Yan PL, Maalouf NM, Best SL, Asplin JR, Shahinian V, Hollingsworth JM. JAMA Netw Open, 2024 Aug 1; 7 (8): e2428953Journal ArticleThiazide Dose, Urine Calcium, and Symptomatic Kidney Stone Events.
DOI:10.1001/jamanetworkopen.2024.28953 PMID: 39172453 -
Hollingsworth JM, Oerline MK, Hsi RS, Crivelli JJ, Krampe N, Asplin JR, Shahinian VB. Am J Kidney Dis, 2024 Jul; 84 (1): 83 - 93.e1.Journal ArticleReal-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study.
DOI:10.1053/j.ajkd.2023.12.015 PMID: 38432593 -
Lin SC, Funk RJ, Ryan AM, Joynt Maddox KE, Hollingsworth JM. Am J Manag Care, 2024 Jun 1; 30 (6): e184 - e190.Journal ArticleBundled payments lead to quality improvements in hospitals' skilled nursing facility referral networks.
DOI:10.37765/ajmc.2024.89566 PMID: 38912933 -
Crivelli JJ, Oerline MK, Maalouf NM, Hsi RS, Krampe N, Smith KB, Best SL, Denton BT, Asplin JR, Shahinian VB, Hollingsworth JM. Journal of Urology, 2024 May; 211 (5S): e417Journal ArticleMP26-11 ADHERENCE TO POTASSIUM CITRATE AND CHANGES IN 24-HOUR URINE STONE RISK PARAMETERS
DOI:10.1097/01.ju.0001009408.66023.77.11 -
Hsi R, Yan P, Smith K, Best S, Asplin J, Crivelli J, Maalouf N, Shahinian V, Hollingsworth J. Journal of Urology, 2024 May; 211 (5S): e419Journal ArticleMP26-15 ASSOCIATIONS BETWEEN THIAZIDE DOSAGE AND URINARY CALCIUM CHANGE WITH SUBSEQUENT KIDNEY STONE EVENTS
DOI:10.1097/01.ju.0001009408.66023.77.15 -
Salka BS, Oerline MK, Yan P, Hsi RS, Crivelli JJ, Asplin JR, Shahinian VB, Hollingsworth JM. Journal of Urology, 2024 May; 211 (5S): e420Journal ArticleMP26-17 RISK OF NEPHROLITHIASIS IN LONG-TERM TOPIRAMATE AND ZONISAMIDE USERS
DOI:10.1097/01.ju.0001009408.66023.77.17 -
Hsi R, Best S, Oerline M, Crivelli J, Asplin J, Maalouf N, Hollingsworth J, Shahinian V. Journal of Urology, 2024 May; 211 (5S): e421Journal ArticleMP26-20 CHANGES IN 24-HOUR URINE PARAMETERS ASSOCIATED WITH SGLT-2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS
DOI:10.1097/01.ju.0001009408.66023.77.20 -
Arivoli K, Valicevic AN, Oerline MK, Hsi RS, Patel SR, Hollingsworth JM, Shahinian VB. Clin J Am Soc Nephrol, 2024 May 1; 19 (5): 565 - 572.Journal ArticlePreventive Pharmacological Therapy and Risk of Recurrent Urinary Stone Disease.
DOI:10.2215/CJN.0000000000000428 PMID: 38345854